Suchergebnisse - "Cai, Yue"

PubPharm (831)

1

Deep learning assists detection of esophageal cancer and precursor lesions in a prospective, randomized controlled study

enthalten in: Science translational medicine | 2024

von Li, S. | Zhang, L. | Cai, Y. | +36

2

Pathophysiology characterization of Alzheimer's disease in South China's aging population : for the Greater-Bay-Area Healthy Aging Brain Study (GHABS)

enthalten in: Alzheimer's research & therapy | 2024

von Liu, Z. | Shi, D. | Cai, Y. | +23

3

Pathophysiology characterization of Alzheimer’s disease in South China’s aging population: for the Greater-Bay-Area Healthy Aging Brain Study (GHABS)

enthalten in: Alzheimer's research & therapy | 2024

von Liu, Z. | Shi, D. | Cai, Y. | +23

4

SlBEL11 regulates flavonoid biosynthesis, thus fine-tuning auxin efflux to prevent premature fruit drop in tomato

enthalten in: Journal of integrative plant biology | 2024

von Dong, X. | Liu, X. | Cheng, L. | +12

5

Targeting pathogenic CD8+ tissue-resident T cells with chimeric antigen receptor therapy in murine autoimmune cholangitis

enthalten in: Nature communications | 2024

von Zhu, H. | Yang, S. | Gao, C. | +12

6

Neoadjuvant Chemotherapy With Oxaliplatin and Fluoropyrimidine Versus Upfront Surgery for Locally Advanced Colon Cancer : The Randomized, Phase III OPTICAL Trial

enthalten in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology | 2024

von Hu, H. | Zhang, J. | Li, Y. | +76

7

Chiral BINOL-phosphate assembled single hexagonal nanotube in aqueous solution for confined rearrangement acceleration

enthalten in: Nature communications | 2024

von Li, K. | Qin, W. | Su, W. | +2

8

Intermolecular Interactions, Morphology, and Photovoltaic Patterns in p-i-n Heterojunction Solar Cells With Fluorine-Substituted Organic Photovoltaic Materials

enthalten in: Small (Weinheim an der Bergstrasse, Germany) | 2024

von Li, Q. | Liao, X. | Sun, Y. | +9

9

Low expression of miR-182 caused by DNA hypermethylation accelerates acute lymphocyte leukemia development by targeting PBX3 and BCL2 : miR-182 promoter methylation is a predictive marker for hypomethylation agents + BCL2 inhibitor venetoclax

enthalten in: Clinical epigenetics | 2024

von Li, D. | Yuan, Y. | Meng, C. | +11

10

Low expression of miR-182 caused by DNA hypermethylation accelerates acute lymphocyte leukemia development by targeting PBX3 and BCL2: miR-182 promoter methylation is a predictive marker for hypomethylation agents + BCL2 inhibitor venetoclax

enthalten in: Clinical epigenetics | 2024

von Li, D. | Yuan, Y. | Meng, C. | +11

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[84]